Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency
The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Abstract
We now report a mutation in the nuclear-encoded flavoprotein (Fp) subunit gene of the succinate dehydrogenase (SDH) in two siblings with complex II deficiency presenting as Leigh syndrome. Both patients were homozygous for an Arg554Trp substitution in the Fp subunit. Their parents (first cousins) were heterozygous for the mutation that occurred in a conserved domain of the protein and was absent from 120 controls. The deleterious effect of the Arg to Trp substitution on the catalytic activity of SDH was observed in a SDH- yeast strain transformed with mutant Fp cDNA. The Fp subunit gene is duplicated in the human genome (3q29; 5p15), with only the gene on chromosome 5 expressed in human-hamster somatic cell hybrids. This is the first report of a nuclear gene mutation causing a mitochondrial respiratory chain deficiency in humans.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“consistent with results of clinical studies linking SdhA mutations to a bioenergetic deficiency rather than a tumor phenotype (7).”
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Diseases of the mitochondrial DNA
Wallace, D. C. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.61.070192.005523 · Cited by 1,319
Biochemical and molecular investigations in respiratory chain deficiencies
Rustin, P., Chretien, D., Bourgeron, T., Gérard, B., Rötig, A., Saudubray, J. M., & Munnich, A. (1994) · Clinica Chimica Acta · doi:10.1016/0009-8981(94)90055-8 · Cited by 1,243
Self-citationIn situ hybridization; a practical approach
(1993) · International Journal of Biochemistry · doi:10.1016/0020-711x(93)90093-t · Cited by 1,220
The NADH:ubiquinone oxidoreductase (complex I) of respiratory chains
Walker, J. E. (1992) · Quarterly Reviews of Biophysics · doi:10.1017/s003358350000425x · Cited by 781
One-step transformation of yeast in stationary phase
Chen, D.-C., Yang, B.-C., & Kuo, T.-T. (1992) · Current Genetics · doi:10.1007/bf00318659 · Cited by 697
In situ hybridization; a practical approach
(1993) · Comparative Biochemistry and Physiology Part A: Physiology · doi:10.1016/0300-9629(93)90060-h · Cited by 648
Pearson's marrow–pancreas syndrome. A multisystem mitochondrial disorder in infancy
Rötig, A., Cormier, V, Blanche, S., Bonnefont, J. P., Ledeist, F., Romero, N., Schmitz, J., Rustin, P., Fischer, A., & Saudubray, J. M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114881 · Cited by 461
Self-citationMandel, J. L., & Chambon, P. (1979) · Nucleic Acids Research · doi:10.1093/nar/7.8.2081 · Cited by 348
Clinical aspects of mitochondrial disorders
Munnich, A., Rustin, P., Rötig, A., Chretien, D., Bonnefont, J. ‐., Nuttin, C., Cormier, V., Vassault, A., Parvy, P., Bardet, J., et al. (1992) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01799603 · Cited by 157
Self-citation
Research works printed but not linked: 1
- Ackrell, B.A.C., Johnson, M.K., Gunsalus, R.P. & Cecchini, G. Structure and function of succinate dehydrogenase and fumarate reductase. In Chemistry and Biochemistry of Flavoproteins (ed. Muller, F.) 3, 229–297 (CRC Press, Inc., Boca Raton, FL, 1990).
Cited by
Items 201–300 of 731
Mitochondrial respiratory chain disorders and the liver
Morris, A. A. M. (1999) · Liver International · doi:10.1111/j.1478-3231.1999.tb00063.x · Cited by 77
Davis, R. L., Liang, C., & Sue, C. M. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63233-3.00010-5 · Cited by 82
Hock, D. H., Robinson, D. R. L., & Stroud, D. A. (2020) · Biochemical Journal · doi:10.1042/bcj20190767 · Cited by 69
Defective complex I assembly due to C20orf7 mutations as a new cause of Leigh syndrome
Gerards, M., Sluiter, W., van den Bosch, B. J. C., de Wit, L. E. A., Calis, C. M. H., Frentzen, M., Akbari, H., Schoonderwoerd, K., Scholte, H. R., Jongbloed, R. J., et al. (2010) · Journal of Medical Genetics · doi:10.1136/jmg.2009.067553 · Cited by 70
The basic science of glomus jugulare tumors
Heth, J. (2004) · Neurosurgical FOCUS · doi:10.3171/foc.2004.17.2.2 · Cited by 70
Incomplete penetrance in mitochondrial optic neuropathies
Caporali, L., Maresca, A., Capristo, M., Dotto, V. D., Tagliavini, F., Valentino, M. L., Morgia, C. L., & Carelli, V. (2017) · Mitochondrion · doi:10.1016/j.mito.2017.07.004 · Cited by 80
Primary and secondary defects of the mitochondrial respiratory chain
Schapira, A. H. V. (2002) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1015629912477 · Cited by 68
Energy defects in Huntington's disease: Why “in vivo” evidence matters
Liot, G., Valette, J., Pépin, J., Flament, J., & Brouillet, E. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.065 · Cited by 76
Schüll, S., Günther, S. D., Brodesser, S., Seeger, J. M., Tosetti, B., Wiegmann, K., Pongratz, C., Díaz, F., Witt, A., Andree, M., et al. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.62 · Cited by 72
Smith, A. C., & Robinson, A. J. (2011) · BMC Systems Biology · doi:10.1186/1752-0509-5-102 · Cited by 75
“In cases of isolated succinate dehydrogenase deficiency the phenotype is highly variable and can include Leigh syndrome [15-17], leukodystrophy [16,17], Kearns-Sayre syndrome [18], cardiomyopathy [19] and mental and motor skill deterioration [20].”
BackgroundRenal involvement in mitochondrial cytopathies
Niaudet, P., & Rötig, A. (1996) · Pediatric Nephrology · doi:10.1007/bf00866789 · Cited by 73
“... hereditary optic neuropathy [24], myoclonic epilepsy with ragged red fibers [25], mitochondrial encephalopathy/lactic acidosis/ stroke-like episodes (MELAS) [26], mitochondrial myopathy and cardiomyopathy [27], Leigh syndrome [28], neuropathy ataxia retinitis pigmentosa (NARP) [29] (Table 1). Only one mutation has…”
BackgroundSelf-citationOxidative stress and aging inCaenorhabditis elegans
Ishii, N. (2000) · Free Radical Research · doi:10.1080/10715760000301371 · Cited by 69
The Genetic Basis of Pheochromocytoma
Gimm, O., Koch, C. A., Januszewicz, A., Opocher, G., & INeumann, H. P. H. (2003) · KARGER eBooks · doi:10.1159/000074657 · Cited by 70
Kašparová, S., Sumbalová, Z., Bystrický, P., Kucharská, J., Liptaj, T., Mlynárik, V., & Gvozdjáková, A. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.09.002 · Cited by 70
“Genetic defects affecting complex II–III activity are associated with basal ganglia degeneration (Bourgeron et al., 1995), comparable defects in experimental animals result in striatal degeneration (Brouillet et al.”
BackgroundHirawake, H., Taniwaki, M., Tamura, A., Amino, H., Tomitsuka, E., & Kita, K. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(99)00071-7 · Cited by 74
Does the Patient Have a Mitochondrial Encephalomyopathy?
DiMauro, S., Bonilla, E., & Vivo, D. C. D. (1999) · Journal of Child Neurology · doi:10.1177/0883073899014001051 · Cited by 65
Mitochondria-targeted Antioxidants as a Prospective Therapeutic Strategy for Multiple Sclerosis
Fetisova, E. K., Chernyak, B. V., Korshunova, G. A., Muntyan, M. S., & Skulachev, V. P. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170316114452 · Cited by 65
The role of mitochondrial electron transport in tumorigenesis and metastasis
Tan, A. S., Baty, J. W., & Berridge, M. V. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.10.016 · Cited by 76
Insights into the Pathogenesis and Treatment of Cancer from Inborn Errors of Metabolism
Erez, A., Shchelochkov, O. A., Plon, S. E., Scaglia, F., & Lee, B. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.03.005 · Cited by 67
“IEM complicated by cancer present a unique clinical challenge because there is an increased risk for toxicity resulting from the additional interaction between chemotherapy and the IEM.”
BackgroundInfluentialLimongelli, G., Masarone, D., D‘Alessandro, R., & Elliott, P. M. (2012) · Future Cardiology · doi:10.2217/fca.11.79 · Cited by 64
Germline Mutations in Cancer Predisposition Genes are Frequent in Sporadic Sarcomas
Chan, S. H., Lim, W. K., Ishak, N. D. B., Li, S.-T., Goh, W. L., Tan, G. S., Lim, K. H., Teo, M. C. C., Young, C. C., Malik, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10333-x · Cited by 68
Di Donato, S. (2000) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005684029429 · Cited by 64
Mitochondria and skin disease: Mitochondria and skin disease
Birch-Machin, M. A. (2000) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.2000.00605.x · Cited by 63
Self-citationSDHA loss of function mutations in a subset of young adult wild-type gastrointestinal stromal tumors
Italiano, A., Chen, C.-L., Sung, Y., Singer, S., DeMatteo, R. P., LaQuaglia, M. P., Besmer, P., Socci, N. D., & Antonescu, C. R. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-408 · Cited by 66
“Germline mutations in SDHA are associated with neurodegenerative diseases such as an early-onset encephalopathy, known as Leigh syndrome [31-34] and a late-onset optic atrophy, ataxia and myopathy [35].”
BackgroundLeukoencephalopathy with accumulated succinate is indicative of SDHAF1 related complex II deficiency
Ohlenbusch, A., Edvardson, S., Skorpen, J., Bjørnstad, A., Saada, A., Elpeleg, O. N., Gärtner, J., & Brockmann, K. (2012) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-7-69 · Cited by 63
“Mutations in the SDHA gene were found to be associated with Leigh syndrome [6], late onset neurodegenerative disease [7] and dilated cardiomyopathy [8].”
BackgroundThe Clinical Spectrum of Mitochondrial Disease in 75 Pediatric Patients
Skladal, D., Sudmeier, C., Konstantopoulou, V., Stöckler‐Ipsiroglu, S., Plecko, B., Bernert, G., Zeman, J., & Sperl, W. (2003) · Clinical Pediatrics · doi:10.1177/000992280304200806 · Cited by 61
Synaptic energy metabolism and neuronal excitability, in sickness and health
Oyarzabal, A., & Marin‐Valencia, I. (2019) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12071 · Cited by 62
Mitochondria and dystonia: The movement disorder connection?
Wallace, D. C., & Murdock, D. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.1817 · Cited by 62
Maragos, W. F., Jakel, R. J., Pang, Z., & Geddes, J. W. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6918 · Cited by 61
Baysal, B. E., & Maher, E. R. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0226 · Cited by 64
“…q 2015 Society for Endocrinology DOI: 10.1530/ERC-15-0226 Printed in Great Britain juvenile encephalopathy (Bourgeron et al. 1995), were demonstrated to be a rare cause of (dominantly inherited) predisposition to PPGL (though penetrance appears to be very…”
BackgroundInfluentialMutations of the SDHB and SDHD genes
Pawlu, C., Bausch, B., & Neumann, H. P. H. (2005) · Familial Cancer · doi:10.1007/s10689-004-4227-4 · Cited by 65
“SDHA belongs to the hydrophilic catalytic part of the complex, and SDHA defects were described to cause ataxia, optic atrophy, and Leigh syndrome, a necrotizing encephalomyelopathy associated with reduced cerebrospinal glucose and intermittent lactic acidemia [3].”
BackgroundMunaro, M., Tiranti, V., Sandonà, D., Lamantea, E., Uziel, G., Bisson, R., & Zeviani, M. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.2.221 · Cited by 64
Triepels, R. H., Hanson, B. J., van den Heuvel, L. P., Sundell, L., Marusich, M. F., Smeitink, J. A., & Capaldi, R. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009903200 · Cited by 60
Rahman, S. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-12-821751-1.00015-4 · Cited by 80
Structure of the human respiratory complex II
Du, Z., Zhou, X., Lai, Y., Xu, J., Zhang, Y., Zhou, S., Feng, Z., Yu, L., Tang, Y., Wang, W., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2216713120 · Cited by 80
“The Arg554Trp (31) mutation abrogates a hydrogen bond with Thr551 within SDHA (Fig.”
BackgroundInverted Low-Copy Repeats and Genome Instability-A Genome-Wide Analysis: HUMAN MUTATION
Dittwald, P., Gambin, T., Gonzaga-Jauregui, C. G., Carvalho, C. M. B., Lupski, J. R., Stankiewicz, P., & Gambin, A. (2012) · Human Mutation · doi:10.1002/humu.22217 · Cited by 70
Szeto, S. S. W., Reinke, S. N., Sykes, B. D., & Lemire, B. D. (2010) · Journal of Proteome Research · doi:10.1021/pr100880y · Cited by 65
Степанова, А., Shurubor, Y. I., Valsecchi, F., Manfredi, G., & Galkin, A. S. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.06.002 · Cited by 62
Mitochondrial diseases in adults
Morgia, C. L., Maresca, A., Caporali, L., Valentino, M. L., & Carelli, V. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13064 · Cited by 66
Sharma, P., Maklashina, E., Cecchini, G., & Iverson, T. M. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2007391117 · Cited by 64
Assembly of mitochondrial succinate dehydrogenase in human health and disease
Cao, K. J., Xu, J., Cao, W., Wang, X., Lv, W., Zeng, M., Zou, X., Liu, J., & Feng, Z. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.07.023 · Cited by 68
Next‐generation sequencing for mitochondrial disorders
Carroll, C. J., Brilhante, V., & Suomalainen, A. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12469 · Cited by 77
“However, mutations in mtDNA could not explain all the heredity of mitochondrial disorders and, in 1995, the first report of a nuclear gene mutation (in SDHA) causing RC deficiency in humans was published (Bourgeron et al., 1995).”
BackgroundMitochondrial Respiratory Chain Diseases and Mutations in Nuclear DNA: A Promising Start?
Sue, C. M., & Schon, E. A. (2000) · Brain Pathology · doi:10.1111/j.1750-3639.2000.tb00276.x · Cited by 57
“There is a wide clinical spectrum of disease associated with Complex II deficiency, including Kearns-Sayre syndrome (30), muscle weakness (13), hypertrophic cardiomyopathy (33), Leigh syndrome (6), optic atrophy and cerebellar ataxia (43), and hereditary paraganglioma (4).”
BackgroundMitochondrial Encephalomyopathies: Diagnostic Approach
DiMauro, S., Tay, S. K. H., & Mancuso, M. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1293.022 · Cited by 66
Mitochondrial Myopathies and the Role of the Pathologist in the Molecular Era
Vogel, H. S. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.3.217 · Cited by 65
“Deficiencies have been associated with Leigh syndrome and a wide spectrum of other disorders although only 3 pathogenic mutations in Complex II genes have been identified (56).”
BackgroundNuclear power and mitochondrial disease
DiMauro, S., & Schon, E. A. (1998) · Nature Genetics · doi:10.1038/883 · Cited by 63
The genetic basis of isolated mitochondrial complex II deficiency
Fullerton, M., McFarland, R., Taylor, R. W., & Alston, C. L. (2020) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2020.09.009 · Cited by 70
Genetic basis of phaeochromocytoma and paraganglioma
Benn, D. E., & Robinson, B. G. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.07.005 · Cited by 59
Mirandola, S. R., de Melo, D. R., Saito, Â., & Castilho, R. F. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22239 · Cited by 66
“…may occur under pathological conditions in which partial inhibition of the enzyme occurs, as a result of either a direct defect in SDH/complex II (Bourgeron et al., 1995; Brouillet et al., 2005; Horváth et al., 2006; Chen et al., 2007) or the accumulation of inhibitors of this enzyme (Ludolph…”
BackgroundModel animals for the study of oxidative stress from complex II
Ishii, T., Miyazawa, M., Onouchi, H., Yasuda, K., Hartman, P. S., & Ishii, N. (2012) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2012.10.016 · Cited by 65
“Homozygous germline mutations affecting the SDHA gene cause Leigh syndrome, a sub-acute necrotizing encephalomyelopathy during infancy [51,52].”
BackgroundRiboflavin metabolism: role in mitochondrial function
Balasubramaniam, S., & Yaplito‐Lee, J. (2020) · Journal of Translational Genetics and Genomics · doi:10.20517/jtgg.2020.34 · Cited by 82
“The first report of a nuclear gene mutation causing a mitochondrial respiratory chain deficiency in humans was identified in two sisters presenting with developmental regression at 10 months of age, pyramidal tract signs, leukodystrophy with early demise, Complex II deficiency, and homozygous mutations (R554W) in the…”
BackgroundApproaches to Finding the Molecular Basis of Mitochondrial Oxidative Phosphorylation Disorders
Kirby, D. M., & Thorburn, D. R. (2008) · Twin Research and Human Genetics · doi:10.1375/twin.11.4.395 · Cited by 63
“Mutations in nuclear-encoded OXPHOS genes were first reported in 1995 (Bourgeron et al., 1995) and their number has been steadily increasing.”
BackgroundTranebjærg, L., Jensen, P. K. A., Van Ghelue, M., Vnencak-Jones, C. L., Sund, S., Elgjo, K., Jakobsen, J., Lindal, S., Warburg, M., Fuglsang-Frederiksen, A., et al. (2001) · Ophthalmic Genetics · doi:10.1076/opge.22.4.207.2220 · Cited by 56
Mukherjee, S., & Ghosh, A. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.04.002 · Cited by 58
Abela, L., Spiegel, R., Crowther, L. M., Klein, A., Steindl, K., Papuc, S. M., Joset, P., Zehavi, Y., Rauch, A., Plecko, B., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176363 · Cited by 54
“Thus ACO2 deficiency lacks typical mitochondrial disease biomarkers, similar to other citric acid cycle defects such as succinate dehydrogenase deficiency [4], succinyl-CoA synthase deficiency [5] and fumarate hydratase deficiency [6, 7].”
BackgroundMitochondrial Neurodegeneration
Zeviani, M., & Viscomi, C. F. (2022) · Cells · doi:10.3390/cells11040637 · Cited by 62
“After the first report concerning two children with an LD phenotype and a point mutation in the gene encoding the flavoprotein (Fp) subunit of succinate dehydrogenase [22], approximately 60 patients have been described with CII deficiency, harboring more than 30 different pathogenic variants in the four structural CII…”
BackgroundThe Saccharomyces cerevisiae succinate dehydrogenase does not require heme for ubiquinone reduction
Oyedotun, K. S., Sit, C. S., & Lemire, B. D. (2007) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2007.09.008 · Cited by 67
“Mutations of the human SDH are associated with a wide variety of clinical manifestations, including tumorigenesis, encephalopathy, optic atrophy and myopathy [11–13].”
BackgroundPhenotypic variability of mitochondrial disease caused by a nuclear mutation in complex II
Pagnamenta, A. T., Hargreaves, I. P., Duncan, A. J., Taanman, J., Heales, S., Land, J. M., Bitner-Glindzicz, M. A. K., Leonard, J. V., & Rahman, S. (2006) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2006.05.003 · Cited by 62
Paraganglioma and pheochromocytoma upon maternal transmission of SDHDmutations
Bayley, J., Oldenburg, R. A., Nuk, J., Hoekstra, A. S., van der Meer, C. A., Korpershoek, E., McGillivray, B., Corssmit, E. P. M., Dinjens, W. N. M., de Krijger, R. R., et al. (2014) · BMC Medical Genetics · doi:10.1186/s12881-014-0111-8 · Cited by 63
“As patients with SDHD-related paraganglioma carry paternally-inherited mutations, a maternal imprint would result in a profound deficiency of succinate dehydrogenase activity, a situation known to cause major developmental defects even when residual enzyme activity is present [19].”
BackgroundStructural basis for malfunction in complex II
Iverson, T. M., Maklashina, E., & Cecchini, G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.408419 · Cited by 53
“The enhanced sensitivity of complex II to oxaloacetate likely reduces enzyme activity to 50% of wild-type levels in patients harboring the R554Wmutation (2).”
BackgroundInfluentialGaster, M., Nehlin, J. O., & Minet, A. D. (2012) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2012.656653 · Cited by 63
Han, Y., Shi, W. M., Rong, J., Zha, S., Guan, X., Sun, H., & Liu, G. (2019) · Environmental Science & Technology · doi:10.1021/acs.est.9b03675 · Cited by 57
Mbaya, E., Oulès, B., Caspersen, C., Tacine, R., Massinet, H., Pennuto, M., Chrétien, D., Munnich, A., Rötig, A., Rizzuto, R., et al. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2010.51 · Cited by 52
Self-citationYap, Z. Y., Strucinska, K., Matsuzaki, S., Lee, S., Si, Y. C., Humphries, K. M., Tarnopolsky, M. A., & Yoon, W. H. (2020) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12248 · Cited by 71
Succinate Dehydrogenase Loss in Familial Paraganglioma: Biochemistry, Genetics, and Epigenetics
Her, Y. F., & Maher, L. J. (2015) · International Journal of Endocrinology · doi:10.1155/2015/296167 · Cited by 58
“SDHA mutations are also associated with Leigh syndrome [71–73].”
BackgroundRecent Advances in the Genetics of Mitochondrial Encephalopathies
Tucker, E. J., Compton, A. G., & Thorburn, D. R. (2010) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-010-0112-8 · Cited by 62
“The first mutation in nuclear DNA causing mitochondrial encephalopathy was identified in 1995 [ 13 ].”
BackgroundLowery, A., Walsh, S. M., McDermott, E. W. M., & Prichard, R. S. (2013) · The Oncologist · doi:10.1634/theoncologist.2012-0410 · Cited by 54
Mitochondrial disorders: Clinical presentation and diagnostic dilemmas
Smeitink, J. A. M. (2003) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1024489218004 · Cited by 52
“Among the different groups of inborn errors of metabolism, mitochondrial disorders are the most frequent, with an estimated incidence of at least 1 in 10 000 live births (Bourgeron et al 1995).”
BackgroundAhlers, P. M., Garofano, A., Kerscher, S., & Brandt, U. (2000) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(00)00160-2 · Cited by 53
Piantadosi, C. A., & Suliman, H. B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709741200 · Cited by 51
A novel mtDNA C11777A mutation in Leigh syndrome
Komaki, H., Akanuma, J., Iwata, H., Takahashi, T., Mashima, Y., Nonaka, I., & Goto, Y.-I. (2003) · Mitochondrion · doi:10.1016/s1567-7249(03)00003-5 · Cited by 50
Coenen, M. J. H., van den Heuvel, L. P., Nijtmans, L. G. J., Morava, É., Marquardt, I., Girschick, H. J., Trijbels, F. J. M., Grivell, L. A., & Smeitink, J. A. M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1662 · Cited by 50
Mitochondrial encephalomyopathies: what next?
DiMauro, S. (1996) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01799110 · Cited by 50
Bandara, A. B., Drake, J. C., & Brown, D. A. (2021) · BMC Molecular and Cell Biology · doi:10.1186/s12860-021-00370-w · Cited by 56
Zantour, B., Guilhaume, B., Tissier, F., Louvel, A., Jeunemaître, X., Gimenez‐Roqueplo, A., & BERTAGNA, X. Y. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510433 · Cited by 49
Bénit, P., Goncalves, J., El‐Khoury, R., Rak, M., Favier, J., Gimenez‐Roqueplo, A., & Rustin, P. (2022) · Biomedicines · doi:10.3390/biomedicines10081788 · Cited by 59
“The mutation caused a severe, yet partial, deficiency of SDH activity, resulting in a tissue-specific involvement [3].”
BackgroundSelf-citationMitochondrial diseases and the role of the yeast models
Rinaldi, T., Dallabona, C., Ferrero, I., Frontali, L., & Bolotin‐Fukuhara, M. (2010) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2010.00685.x · Cited by 56
Mitochondrial Disease in Childhood: Nuclear Encoded
Goldstein, A. C., Bhatia, P., & Vento, J. M. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0185-6 · Cited by 53
“The first identified nuclear gene mutation responsible for mitochondrial disease was a subunit of complex II, succinate dehydrogenase complex, subunit A (SDHA), in siblings with Leigh syndrome [31], but only mutations in SDHA are implicated in primary mitochondrial disease, and these are inherited in an autosomal rece…”
BackgroundNuclear Genetic Defects of Mitochondrial ATP Synthase
HEJZLAROVÁ, K., MRÁČEK, T., VRBACKÝ, M., KAPLANOVÁ, V., KARBANOVÁ, V., NŮSKOVÁ, H., PECINA, P., & HOUŠTĚK, J. (2014) · Physiological Research · doi:10.33549/physiolres.932643 · Cited by 48
“Bourgeron et al. (1995) reported the first defect in a nuclear gene https://doi.org/10.33549/physiolres.932643 S58 Hejzlarová et al. Vol. 63 resulting in a mitochondrial respiratory chain deficiency – a mutation in SDHA gene affecting complex II, succinate dehydrogenase.”
BackgroundInfluentialMetabolic intermediates in lactic acidosis: compounds, samples and interpretation
Poggi-Travert, F., Martin, D., de Villemeur, T. B., Bonnefont, J., Vassault, A. J., Rabier, D., Charpentier, C., Kamoun, P., Münnich, A., & Saudubray, J. (1996) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01799109 · Cited by 50
Mitochondrial protein dysfunction in pathogenesis of neurological diseases
Wang, L., Yang, Z., He, X., Pu, S., Yang, C., Wu, Q., Zhou, Z., Cen, X., & Zhao, H. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.974480 · Cited by 49
“Although fewer neurological disorders are reported to be linked to the mutations in CII, multiple types of mutations in SDHA, and SDHB, as well as one assembly factor SDHAF1, have been reported to cause LS or LS-like symptoms (Bourgeron et al., 1995; Birch-Machin et al., 2000; Pagnamenta et al., 2006; Jain-Ghai et al.…”
BackgroundMedici, V., Kieffer, D. A., Shibata, N. M., Chima, H., Kim, K., Cánovas, Á., Medrano, J. F. F., Islas‐Trejo, A., Kharbanda, K. K., Olson, K., et al. (2016) · Epigenetics · doi:10.1080/15592294.2016.1231289 · Cited by 49
“Human mutations of SDHA have been associated with Leigh syndrome, which is characterized by progressive neurodegenerative disease and developmental delay.(25) We observed upregulation of oxidative phosphorylationrelated gene transcript levels in fetal livers, but downregulation of most of the same gene transcripts in…”
BackgroundDiMauro, S. (2004) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2004.08.003 · Cited by 63
The energy-transducing NADH: quinone oxidoreductase, complex I
Yano, T. (2002) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(02)00011-0 · Cited by 62
Rescue of TCA Cycle Dysfunction for Cancer Therapy
Marquez, J. C., Flores, J., Kim, A. H., Nyamaa, B., Nguyen, A. T. T., Park, N., & Han, J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122161 · Cited by 50
Mitochondrial Encephalomyopathies
Oldfors, A., & Tulinius, M. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.3.217 · Cited by 51
“The first report on a nuclear OXPHOS gene mutation was in a patient with LS and complex II deficiency (22).”
BackgroundMitochondrial encephalomyopathies: the enigma of genotype versus phenotype
MORGAN-HUGHES, J. A., & Hanna, M. G. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00162-5 · Cited by 56
Searching for nuclear-mitochondrial genes
Chinnery, P. F. (2003) · Trends in Genetics · doi:10.1016/s0168-9525(02)00030-6 · Cited by 47
Marín-García, J., & Goldenthal, M. J. (2002) · Revista Española de Cardiología · doi:10.1016/s0300-8932(02)76802-4 · Cited by 68
Mitochondrial diseases: a nosological update
Filosto, M., & Mancuso, M. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00777.x · Cited by 59
“Mutations in the gene encoding the flavoprotein subunit of complex II (SDHA) have been described in a family with a syndrome characterized by optic atrophy, ataxia and proximal myopathy (44) and in cases of Leigh syndrome (45), while mutations in SDHC ed SDHD (gene encoding cybS protein cytochrome b small subunit), ha…”
BackgroundTanji, K., & Bonilla, E. (2007) · Methods in cell biology · doi:10.1016/s0091-679x(06)80006-3 · Cited by 45
Lu, H., Wang, X., Li, M., Ji, D., Liang, D., Liang, C., Liu, Y., Zhang, Z., Cao, Y., & Zou, W. (2022) · Cells · doi:10.3390/cells12010020 · Cited by 52
“Since the first case of MD caused by a nDNA mutation was reported in 1985 [72], various nDNA mutations causing MDs have been successively identified: first, mutations in genes encoding respiratory chain subunits, such as those associated with complex I activity [73,74]; second, nuclear genes encoding proteins involved…”
Courage, C., Jackson, C. B., Hahn, D., Euro, L., Nuoffer, J., Gallati, S., & Schaller, A. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37986 · Cited by 52
“Up to date only SDHA (OMIM #600857), SDHB (OMIM #185470), SDHD (OMIM #602690) and SDHAF1 (OMIM #612848] have beendescribed as cause of a predominantly recessively inherited mitochondrial disorder [Bourgeron et al., 1995; Alston et al., 2012; Jacksonetal., 2014].”
BackgroundInfluentialHow is Mitochondrial Biogenesis Affected in Mitochondrial Disease?
CHABI, B., ADHIHETTY, P. J., LJUBICIC, V., & HOOD, D. A. (2005) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000177426.68149.83 · Cited by 44
Takeo, S., Kokaze, A., Ng, C. S., Mizuchi, D., Watanabe, J., Tanabe, K., Kojima, S., & Kita, K. (2000) · Molecular and Biochemical Parasitology · doi:10.1016/s0166-6851(00)00185-7 · Cited by 44
MRI of Five Patients with Mitochondrial Neurogastrointestinal Encephalomyopathy
Millar, W. S., Lignelli, A., & Hirano, M. (2004) · American Journal of Roentgenology · doi:10.2214/ajr.182.6.1821537 · Cited by 44
The power of yeast to model diseases of the powerhouse of the cell
Claypool, S. M. (2012) · Frontiers in bioscience · doi:10.2741/4098 · Cited by 52
“Seven mutations in SDHA have been shown to cause Leigh syndrome (216-221).”
BackgroundMeng, F., He, Z., Tang, X., Zheng, J., Jin, X., Zhu, Y., Ren, X., Zhou, M., Wang, M., Gong, S., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000530 · Cited by 44
“The activity of complex II (succinate ubiquinone oxidoreductase) exclusively encoded by the nuclear DNA was examined by the artificial electron acceptor DCPIP (50, 51).”
MethodInfluentialAtaxia in mitochondrial disorders
Zeviani, M., Simonati, A., & Bindoff, L. A. (2011) · Handbook of clinical neurology · doi:10.1016/b978-0-444-51892-7.00022-x · Cited by 47
“The first report concerned two children with a Leigh phenotype and a point mutation in the gene encoding the flavoprotein (Fp) subunit of succinate dehydrogenase (Bourgeron et al., 1995).”
BackgroundMolecular diagnostics of mitochondrial disorders
Rötig, A., Lebon, S., Zinovieva, E., Mollet, J., Sarzi, E., Bonnefont, J., & Münnich, A. (2004) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2004.07.007 · Cited by 46
“Until now, only mutations in the SDH1 gene have been identified in patients with isolated complex II deficiency and Leigh syndrome [26].”
BackgroundSelf-citation
Metadata
- Authors
- Bourgeron, T., Rustin, P., Chretien, D., Birch-Machin, M., Bourgeois, M., Viegas-Péquignot, E., Munnich, A., & Rötig, A.
- Affiliations
- Hôpital Necker-Enfants Malades (FR)
- Venue
- Nature Genetics
- Published
- 1995-10
- Volume
- 11
- Issue
- 2
- Pages
- 144-149
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1969931826
- Cited by
- 730
- References
- 36
- Citations by year
- 2026: 6 · 2025: 14 · 2024: 12 · 2023: 12 · 2022: 18 · 2021: 21 · 2020: 21 · 2019: 20 · 2018: 18 · 2017: 22 · 2016: 21 · 2015: 22 · 2014: 24 · 2013: 22 · 2012: 39
- FWCI
- 8.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- succinate dehydrogenase, Leigh syndrome, mitochondrial respiratory chain deficiency, nuclear gene mutations, homozygous mutation, conserved domains, catalytic activity, gene duplication, yeast complementation
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Cattle, Cell Nucleus, Chromosome Mapping, Chromosomes, Human, Pair 3, Cloning, Molecular, Consanguinity, Electron Transport Complex IV, Female, Fibroblasts, Homozygote, Humans, Lymphocytes, Male, Mitochondria, Mitochondria, Muscle, Molecular Sequence Data, Multienzyme Complexes, Nuclear Family, Oxidoreductases, Pedigree, Saccharomyces cerevisiae, Succinate Dehydrogenase, Restriction Mapping, Mutagenesis, Site-Directed, Point Mutation, Sequence Homology, Amino Acid, DNA Primers, Muscle, Skeletal, Electron Transport Complex II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.